Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.76
-0.33 (-1.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
Immunome Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Immunome stock have an average target of 26.89, with a low estimate of 18 and a high estimate of 36. The average target predicts an increase of 36.08% from the current stock price of 19.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunome stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 4 | 4 | 4 | 5 |
| Buy | 4 | 5 | 5 | 5 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 9 | 9 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +82.19% | Dec 1, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $25 → $33 | Buy | Maintains | $25 → $33 | +67.00% | Nov 17, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +31.58% | Sep 22, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +31.58% | Sep 5, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +26.52% | Aug 25, 2025 |
Financial Forecast
Revenue This Year
7.45M
from 9.04M
Decreased by -17.61%
Revenue Next Year
6.58M
from 7.45M
Decreased by -11.72%
EPS This Year
-2.31
from -5.00
EPS Next Year
-2.61
from -2.31
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.4M | 27.9M | ||||
| Avg | 7.4M | 6.6M | ||||
| Low | 6.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.5% | 274.9% | ||||
| Avg | -17.6% | -11.7% | ||||
| Low | -25.2% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.93 | -2.06 | ||||
| Avg | -2.31 | -2.61 | ||||
| Low | -2.35 | -3.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.